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Abstract
Background: During a substantial elevation in scarlet fever (SF) notifications in 2014 a national genomic study was
undertaken of Streptococcus pyogenes (Group A Streptococci, GAS) isolates from patients with SF with comparison
to isolates from patients with invasive disease (iGAS) to test the hypotheses that the increase in SF was due to either
the introduction of one or more new/emerging strains in the population in England or the transmission of a known
genetic element through the population of GAS by horizontal gene transfer (HGT) resulting in infections with an
increased likelihood of causing SF. Isolates were collected to provide geographical representation, for approximately
5% SF isolates from each region from 1st April 2014 to 18th June 2014. Contemporaneous iGAS isolates for which
genomic data were available were included for comparison. Data were analysed in order to determine emm gene
sequence type, phylogenetic lineage and genomic clade representation, the presence of known prophage elements
and the presence of genes known to confer pathogenicity and resistance to antibiotics.
Results: 555 isolates were analysed, 303 from patients with SF and 252 from patients with iGAS. Isolates from patients
with SF were of multiple distinct emm sequence types and phylogenetic lineages. Prior to data normalisation, emm3
was the predominant type (accounting for 42.9% of SF isolates, 130/303 95%CI 37.5–48.5; 14.7% higher than
the percentage of emm3 isolates found in the iGAS isolates). Post-normalisation emm types, 4 and 12, were
found to be over-represented in patients with SF versus iGAS (p < 0.001). A single gene, ssa, was over-represented in
isolates from patients with SF. No single phage was found to be over represented in SF vs iGAS. However, a “meta-ssa”
phage defined by the presence of :315.2, SPsP6, MGAS10750.3 or HK360ssa, was found to be over represented. The
HKU360.vir phage was not detected yet the HKU360.ssa phage was present in 43/63 emm12 isolates but not found to
be over-represented in isolates from patients with SF.
Conclusions: There is no evidence that the increased number of SF cases was a strain-specific or known mobile
element specific phenomenon, as the increase in SF cases was associated with multiple lineages of GAS.
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Background
Streptococcus pyogenes (Lancefield group A streptococ-
cus, GAS) is a common cause of bacterial throat infec-
tions, and also causes mild to severe skin and soft tissue
infections, including impetigo, erysipelas and necrotizing
fasciitis. GAS can also cause systemic infections including
septicaemia and meningitis, which can be fatal. Estimated
annual incidence for invasive GAS (iGAS) infection in
industrialised countries is approximately 3 per 100,000
per year [1]. Scarlet fever (SF) is characterised by rash,
“strawberry tongue”, and exudative pharyngitis and is
thought to be due to infection with GAS secreting super-
antigens [2]. SF typically has a cyclical incidence, with re-
surgences occurring on average every 4 years [3]. In
England and Wales the incidence of SF has been in de-
cline for several decades, reducing from 250 notifications
per 100,000 population per year in 1944 to <5 per 100,000
per year in the 2000s, until the marked increase in 2013/
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2014 season for which 25 notifications per 100,000 were
noted in the 2013/2014 season [4, 5]. The 2013/14 routine
surveillance of notifiable infectious diseases showed an
unprecedented increase in the number of cases of SF des-
pite iGAS numbers remaining within expected seasonal
range [6]. A study in the North-West London indicated
and association of SF with emm3 lineage isolates and an
increase in emm3 and emm4 infections co-incident with
the upsurge [7]. Previous studies have shown an over-
representation of ssa, speA and speC in SF isolates [8].
Similarly, multiple emm1 SF isolates were recently noted
in Hong Kong encoding SSA [2]. In England, a novel
phage has been described in emm3 lineage invasive and
non-invasive GAS strains encoding SpeC [9]. Previous
studies have also shown that in epidemic periods specific
emm gene sequence types may predominate within the
mixed population of strains present including in Taiwan
(1998–2007) [10], Hong Kong [11] and also in a study of
pharyngeal isolates from patients with and without SF in
Lisbon 2002–2008 [8]. Due to the unprecedented increase
in the incidence of SF in England and Wales, a national
incident management team was convened by PHE which
initiated investigation of isolates of GAS from patients
with SF, with the intention of collating a representative se-
lection of SF isolates from all regions of England for gen-
omic analysis. This was undertaken to determine whether
the increase in SF was due to the introduction of new/
emerging strain/s into the population or transmission of a
known genetic element through the population of GAS by
horizontal gene transfer (HGT) resulting in infections
with an increased likelihood of causing SF.
Results
A total of 555 isolates of which 303 were from SF pa-
tients and 252 from iGAS patients were included in the
analysis.
emm gene typing
Analysis of 555 isolates in total including 303 from pa-
tients with SF and 252 from patients with iGAS indi-
cated 16 emm types (emm 1, 2, 3, 4, 6, 9, 12, 22, 28, 44,
58, 75, 77, 82, 87 and 89) in the study population from
patients with SF, with emm 1, 3, 4, 6 and 12, each ac-
counting for more than 5% of the population (Fig. 1 and
Additional file 1). Isolates of 26 emm types (emm 1, 2, 3,
4, 5, 6, 9, 12, 18, 22, 28, 44, 53, 58, 73, 75, 76, 77, 81, 82,
87,89, 90, 94, 103 and 171 were identified among the
252 isolates of patients with iGAS, with emm 1, 3, 12,
28, and 89 each accounting for more than 5% of the
population (Fig. 1 and Additional file 1). Isolates from
patients with SF were of multiple distinct emm sequence
types with emm3 predominating, accounting for 42.9%
(130/303 95%CI 37.5–48.5); this was 14.7% higher than
the proportion seen amongst the iGAS isolates (Fig. 1
and Additional file 1). Although there appeared to be an
association between emm3 and SF phenotype, this was not
found to be statistically significant following application of
Bonferoni’s correction, when sampling bias per submitting
region (using the normalised random selection) was con-
sidered. This association was also not found to be signifi-
cant when genomic lineage (normalised genomic selection)
were taken into consideration (Fig. 1 and Additional file 1).
Two emm types (emm types 4 and 12) were consistently
found to be over-represented in isolates from patients with
SF versus iGAS (p = 0.0008 and 0.0014, respectively) fol-
lowing application of Bonferroni’s correction.
Phylogenetic analysis
The population structure of SF and iGAS isolates (max-
imum likelihood) is depicted in Fig. 2. The radial branch
lengths within the tree represent approximately 4000
SNPs. The iGAS and SF isolate sequences were found to
be evenly spread throughout the phylogeny with no ob-
vious association within a single or small number of
clades. For comparison the percentage of historic re-
ferred isolates per emm type from patients with SF is in-
cluded from 2004 to 2014 (Additional file 2).
Population structure, hierarchical clustering
Isolates were grouped into genomic clusters based on
hierarchical clustering using the number of SNP differ-
ences as the distance metric and complete linkage at less
than 26 SNP differences. 161 genomic clusters were
identified, of which the majority had less than 5 isolates..
The Cochran-Mantel-Haenszel test was used (April to
June) to look for association of genomic clusters with
differing phenotypes, with results plotted by region and
time (Fig. 3). Of the 16 with more than 5 isolates per
genomic cluster using the Cochran-Mantel-Haenszel, 6
did not have over-representation of SF vs iGAS or vice
versa, 7 were over-represented in SF isolates vs iGAS
and 3 were over-represented in iGAS. When looking at
specific genomic clusters (<26 SNP) per region over time
(Fig. 3) all genetic clusters with more than 5 representa-
tive strains had isolates found in patients with iGAS or
SF. In many (7/8) of the larger clusters with greater than
15 isolates (cluster numbers: 2, 3, 4, 5, 8, 11, 15 on Fig. 3)
the same genomic SNP clusters were found to have rep-
resentative isolates from patients with iGAS and SF dis-
tributed throughout the time period studied. In genetic
clusters with smaller numbers (n < 15), uneven sampling
will have had a greater impact on the distribution and
this may account for the apparent less even distribution
of iGAS and SF isolates over time in smaller clusters.
Not all regions were able to provide sufficient SF iso-
lates, with one not submitting any, and others submitted
more than the 5% target (Additional file 3).
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Age and genomic cluster analysis
All genomic clusters where SF isolates were over-
represented also contained isolates from adults with iGAS,
indicating absence of a specific strain lineage associated
with SF (Fig. 4).
Horizontal gene transfer (HGT)
Analysis of the association of genes with isolates from
cases of SF versus iGAS showed that ssa was present
in all SF isolates (Additional file 4). However, ssa was
also found in isolates from patients with iGAS (using
Fig. 1 emm gene type in patients with SF and iGAS. emm types detected in > 5% population of patients with SF and iGAS (note emm 4 and 6
were <5% for iGAS and are included for comparison to SF). Note the total isolate number per emm type and for all isolates and normalised random
and genomic selection is included, in addition to percentage, 95% confidence intervals and the p value obtained using Fisher’s exact test (with
Bonferroni’s correction) to compare number of isolates per emm type per study selection groups versus iGAS isolates (blue star indicates p = <0.05)
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normalised random selection of isolates from the
study period in 2014).
Phage content
Of 57 phage sequences included in the study (Additional
file 5) 54 were previously described within emm types 1,
2, 3, 4, 5, 6, 12, 18, 28 [12–14]. Examination of the sub-
set of isolates that consisted of only these emm types
(242 SF and 177 iGAS isolates) revealed that no phage
was significantly associated with isolates from patients
with SF. However, previous reports have linked presence
of ssa gene with SF, We hypothesised that closely related
phage may be carrying ssa gene, but may not be indi-
vidually associated with the SF samples. To test this hy-
pothesis, new “meta-ssa” phage was defined to be
present if any one of the following phage were present:
315.2, SPsP6. MGAS10750.3 or HK360ssa. These phage
have been characterised to contain ssa gene [11, 14, 15].
Repeating the phage association analysis with the add-
itional phage showed association of the “meta-ssa” with
SF (Fisher’s Exact Test p = 0.0000025, Bonferroni correc-
tion = 0.00014). Association of “meta-ssa” phage, but not
indivdual ssa carrying phages points towards a poly-
clonal population of SF phage. Although not significantly
over-represented in emm 12, isolates from patients with
SF compared to those with iGAS, a phage with >95%
identity to the HKU360.ssa phage {Davies, 2015 #18}
was found in 43/63 (68.3%, 95% CI 55.–78.5) emm12
isolates and 1/28 (3.5%, 95% CI 0.01–19.2) of emm28
isolates, and were absent from all other isolates in
this study.
Discussion
Due to the unprecedented increase in the incidence of
SF in England and Wales in 2014 genomic analysis was
undertaken to determine whether the increase in SF was
due to the introduction of new/emerging strain/s into
the population or transmission of a known genetic elem-
ent through the population of GAS by HGT resulting in
infections with an increased likelihood of causing SF.
This study found no evidence to support the hypothesis
that the increased number of cases of SF was due to the
introduction of, or increase in, a single genetic lineage
within the population or to a known virulence gene/
phage phenomenon as analysis of the population struc-
ture (Fig. 2) showed that isolates belonging to multiple
diverse genetic lineages were present in patients with SF.
Isolates from the same lineages were also present in pa-
tients with iGAS. Further analysis revealed seven defined
genomic clusters (<26 SNPs) with >5 isolates; seven
over-represented in patients with SF versus iGAS, and
three in iGAS versus SF. However, SF and iGAS isolates
were found in all genomic clusters with >5 isolates. It is
possible that isolates within these clusters are more
commonly carried in the throat or have greater propen-
sity to cause invasive infection in humans than other
lineage strains. However, the prevalence of these lineages
in asymptomatic individuals is not known. Nonetheless,
all 16 clusters were found in differing geographical areas
and across the time period studied, indicating wide-
spread presence in the population. Studies have shown
that an expansion of an iGAS clone from patients in the
San Francisco Bay area during 2005–2008 differed on
Fig. 2 Maximum likelihood phylogenetic tree. Maximum likelihood phylogeny with emm type. RAxML phylogeny based on SNP variants of SF
and iGAS mapped to MGAS2096. SF isolates are coloured red and iGAS isolates in blue (April to June) The radial branch lengths within the tree
represent approximately 4000 SNPs
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average by only 10 SNPs within 14 isolates [16] The
phylogenetic and epidemiologic data suggest that these
14 isolates constitute a distinct clone that caused a geo-
graphic cluster of invasive infections [16, 17]. Therefore,
the variation observed within the isolates in <26 SNP
clusters included in this study must have arisen over a
long time period and not within the documented period
of increase in SF in 2014.
In 2009 a rise was noted in SF in Vietnam [referenced
in [18], and in 2011 increases of SF were reported in
China and Hong Kong [2, 11, 18, 19]. These increases
were attributed to mixed emm lineage clones with
multiple clones of emm12 predominating, followed by
emm1 including strains in which an integrative conjuga-
tive element encoding resistance to tetracycline (TetM),
erythromycin (ErmB) and clindamycin, and bacterio-
phage HKU488.vir encoding superantigens SSA and
SpeC were noted [2, 17]. The finding from this study
that the ssa gene was significantly associated with iso-
lates from patients with SF is not surprising, as this is
consistent with findings reported by other smaller stud-
ies [2, 8]. It has been speculated that in a single emm
lineage the acquisition of ssa can confer potential
changes in disease and pathogenicity [2]. However this
Fig. 3 Genomic cluster (<26 SNP) per region and time. Sixteen genomic clades (April to June) with more than 5 referred isolates are plotted - the
number in title boxes represent the arbitrary cluster number followed by the emm type. Those clusters significantly associated with iGAS and SF
are coloured with blue and red headers respectively
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has not been demonstrated in multiple lineages, and is
unlikely to occur within an entire population of multiple
lineages within the limited time period of a few months.
In terms of phage, no single known phage was found in
this study, rather several differing phage carrying ssa in
isolates from patients with SF were noted. However,
strains were not analysed for as yet undiscovered phage
harbouring ssa or additional genetic factors, hence such
genetic elements cannot be fully discounted.
In this study several emm GAS lineages were found
in patients with SF, similar to that seen historically in
England (Additional file 2). Two emm lineage clusters
were found to be over-represented in SF isolates ver-
sus iGAS; emm4 and emm12, consistent with findings
from North West London of an over-representation
of emm4 [7]. These two emm lineages were not found
within the same phylogenetic major clade (Fig. 2). All
published data regarding large increases in wide geo-
graphic areas in SF have involved multiple emm
lineage strains, albeit with a single predominant emm
lineage described for each study, such as emm12 in
Taiwan, China and Hong Kong in 2011 [10, 11, 19].
The predominant strain emm lineage in this study
was also found to be emm3. However this lineage was
Fig. 4 Age and genomic cluster. Strains of the same genomic clades were found in both adult and child populations. Strains within specific
genomic clusters overrepresented in SF (red title boxes) were also found in adult patients with iGAS. Similarly, clusters over-represented in iGAS
(blue) all contained cases of SF
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not significantly over-represented in isolates from pa-
tients with SF versus iGAS, unlike Turner et al. [7]
comparison to isolates from the upper respiratory
tract. Historical submissions of isolates from 2004 to
2015 from patients with SF indicate an annual fluctuation
in the predominant emm type strain per annum, including
emm3, 4 and 12 and could indicate type specific fluctu-
ation in population immunity (Additional file 2). However
these isolates are submitted on an ad hoc basis and are
not from a defined sampling scheme. Changes in predom-
inant emm types in children with SF in the Beijing popula-
tion over time and with area specific changes have
recently been documented [20].
Further study of two genetic elements recently discov-
ered within some emm12 lineage strains (the integrative
and conjugative element ICE-emm12, encoding genes
for tetracycline and macrolide resistance, and prophage
ΦHKU.vir, encoding the superantigens SSA and SpeC,
as well as the DNase Spd1) may uncover an important
role for these elements in conferring the SF phenotype
in patients [2, 11]. The HKU360.vir phage described in
some isolates from the 2011 Hong Kong SF increase
[11] was not present in isolates in this study, whereas
the HKU360.ssa was present in the majority of emm12
type isolates but was not found to be over-represented
in isolates from patients with SF. In summary, the large
observed increase in the number of SF cases cannot be
attributed to a single genetic factor. Without being able
to determine the proportion of the different lineages and
the genetic factors they carry within the asymptomatic/
carriages population it is not possible to determine if the
lineages observed in the disease causing isolates mirrors
those seen in the population as whole. If the population
structure within these two human host groups was simi-
lar it would lend weight to alternative hypotheses such
as the increase in SF cases being due to alternative factors.
These could include host population immunity status,
concurrent circulation of other predisposing pathogens
such as respiratory viruses, potential declining healthcare
attendance for patients with GAS infection resulting in in-
creased likelihood for infection to progress to SF and re-
duction in the use of antimicrobials affecting pharyngeal
carriage in the population.
Geographically representative sampling was limited by
isolates available in clinical laboratories and consequently
9 of 15 regions of England submitted fewer samples than
the requested 5% sample and multiple submissions from
localised clusters could not be discounted during collec-
tion. Isolates from periods outside the study period, in-
cluding those during the height of the epidemic peak were
not available for comparison. Therefore sufficient isolates
were not available to undertake a comprehensive genome
wide association study to determine additional other/novel
genetic factors associated with SF.
Conclusions
The increase in SF cases was not caused by the introduc-
tion of a single or dominant clone but is associated with
multiple lineages within the GAS population currently cir-
culating in England. The ssa gene was over-represented in
isolates from patients with SF. Although no single ssa car-
rying phage was found to be over represented in SF vs
iGAS, the “meta-ssa” phage defined by the presence of
:315.2, SPsP6. MGAS10750.3 or HK360ssa (phages previ-
ously shown to contain ssa, Additional file 5), was found
to be over represented in isolates from patients with SF.
The HKU360.vir phage described in some isolates from
the 2011 Hong Kong SF increase [11] was not present in
any of the 555 isolates analysed in this study. The
HKU360.ssa phage associated with some emm12 isolates
from the 2011 Hong Kong SF study was present in 43/63
emm12 isolates, but was not found to be over-represented
in isolates from patients with SF. Two emm types, 4 and
12, were found to be over-represented in patients with SF
versus iGAS (p = 0.0008 and p = 0.0014 respectively), but
were not restricted to SF patients. The emm3 lineage iso-
lates were not found to be over-represented following gen-
omic and regional normalisation indicating a large
proportion of emm3 isolates were received from a single
region. Other factors need to be examined to determine
contribution to the national reported increase in SF.
Methods
Aim, design and setting
This genomic study was undertaken to determine
whether the increase in SF in England 2014 was due to
the introduction of new/emerging strain/s into the
population or transmission of a known genetic element
through the population of GAS by horizontal gene trans-
fer (HGT) resulting in infections with an increased like-
lihood of causing SF.
Strain collection
In an attempt to assemble a representative sample of cir-
culating GAS isolates from SF a request was made to
microbiology laboratories in England to submit routinely
obtained isolates of GAS to PHE Colindale. A sampling
scheme was developed based on number of SF notifica-
tions per region with each requested to supply a target
number of isolates equivalent to ~5% of SF notifications
from each of the 15 regions, for specimens taken be-
tween 1st April 2014 and 18th June 2014 submitted to
the National Reference Laboratory. A total of 15 regions
were defined as follows: Anglia & Essex; Avon, Glouces-
tershire & Wiltshire; Cheshire & Merseyside; Cumbria &
Lancashire; Devon, Cornwall & Somerset; East Midlands;
Greater Manchester; Kent, Surrey & Sussex; London;
North East; South Midlands & Hertfordshire; Thames
Valley; Wessex; West Midlands; Yorkshire & Humber.
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Not all regions were able to provide sufficient SF isolates,
with one not submitting any, and others submitted more
than the 5% target (Additional file 3). A control groups
comprised of contemporaneous iGAS isolates routinely
submitted as part of ongoing national surveillance, for
which genomic data were already available, were included
in the analysis. A total of 555 isolates of which 303 were
from SF patients and 252 from iGAS patients were in-
cluded in the analysis. Isolates received outside of the tar-
get dates were excluded from this analysis.
Genomic sequencing (GS)
Genomic DNA was extracted from 5 to 6 colonies per
isolate after 24 h incubation at 37 °C on 5% horse blood
agar (PHE media services) using the Qiasymphony (Qia-
symphony DNA Mini kit, Qiagen) after after pre-lysis at
37 °C for 30 min and 100 °C for 10 min with 30 units
mutanolysin and 0.06 mg hyaluronisdae (Sigma-
Aldridch). Paired end multiplex libraries were created
with the Illumina Nextera XT sample preparation kit,
followed by sequencing on Illumina Hi-Seq 2500, with a
read length of 2x100 bp. The Illumina sequence short
read FASTQ files from all isolates were trimmed for
quality by removing leading and trailing nucleotides of
Phred quality score Q < 30, truncating a read if a sliding
window of size 4 has a mean Q < 30, and dropping a
whole read if shorter than 50 nucleotides after trimming.
Analysis of association of emm type with phenotype
The emm gene type of all isolates was determined from
genomic sequence (GS) data. Over-representation of
emm gene type in isolates from patients with SF versus
iGAS was examined using Fisher’s Exact test with Bon-
ferroni’s correction (R statistics package). A limited
number of additional strains of GAS were included from
other periods or locations for comparison including the
emm12 lineage strain reported in Hong Kong [11] and
an emm3 lineage strain from a period of enhanced sur-
veillance in the UK from 2008–2009 [9].
Phylogenetic analysis, tree generation
Reads were mapped to the NCBI reference genome
MGAS2096 (emm12) using bwa. Variants were called
using GATK 2.6.5 and parsed to retain high quality sin-
gle nucleotide polymorphisms (SNPs) based on the fol-
lowing conditions: depth of coverage (DP) ≥5, AD ratio
(ratio between variant base and alternative bases) ≥0.8,
Mapping Quality (MQ) ≥30, ratio of reads with MQ0 to
total number of reads ≤0.05. All positions that fulfilled
the filtering criteria in >0.9 of the samples were joined
to produce a multiple fasta format file where the se-
quence for each strain consists of the concatenated vari-
ants. This file was used as an input to generate a
maximum likelihood (ML) tree using RAxML [21] as
implemented on the CIPRES portal [22] with the follow-
ing parameters –m (substitutionModel) GTRCAT –b
(bootstrapRandomNumberSeed) 12345 -# (numberO-
fRuns) 100 –c (numberOfCategories) 25.
Phylogenetic analysis, population structure
The population structure of isolates was analysed by
grouping them into genomic clusters based on complete
linkage hierarchical clustering using the number of SNP
differences as the distance metric and a threshold of 25.
The Cochran-Mantel-Haenszel test was used to look for
genomic clusters associated with cases of SF and iGAS.
Isolate subset normalisation
In order to account for tests across multiple regions that
may have had different data collection/sending strat-
egies, as well as, multiple samples sent from the same
outbreak, analysis was performed on three isolate sub-
sets (isolate numbers per group and region are listed
Additional file 3):
1) All isolates included in the study (total selection,
stratified by region if more than 1 isolate was
submitted from the region).
2) For regions where more than 5% of total isolates in the
region were submitted, isolates were downsampled to
the target 5% using random selection, while
maintaining the proportion of observed emm
types. For the regions where 5% of total cases in the
region or less were submitted, no downsampling was
performed (normalised random selection).
3) To control for inclusion of multiple isolates
submitted from the same outbreak, all isolates were
clustered using hierarhical clustering with complete
linkage on SNP differences between isolates to
create genetic SNP clustering. For clusters (<26
SNPs) with multiple isolates per region, a random
isolate was picked to be “representative” of the
region. This process (normalised genomic selection)
was performed for both iGAS and SF isolates.
Gene/Accessory genome analysis/Horizontal gene transfer
(HGT)
To determine if HGT of specific genetic elements into iso-
lates with different genetic backgrounds had occurred, the
presence and absence of genes encoding known virulence
factors and antibiotic resistance markers were determined
(Additional file 4). The reads from GS were mapped to
the sequences of known virulence factors (including
superantigens and antibiotic resistance genes) and the
resulting bam files parsed to find which genes/alleles were
present in each isolate. This procedure was carried out
using the GeneFinder software; an in-house algorithm that
uses bowtie2 to map sequence reads to reference
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sequences of interest and Samtools vs 0.1.18 to genenerate
an mpileup file, which is then parsed for the rapid detec-
tion of sought sequences [23]. Genes showing >90% nu-
cleotide identity over the full length of their sequences
were considered to be present. Accessory gene content in
isolates from patients with SF and iGAS was examined.
Strains in genomic clusters comprising >5 strains were
examined for the presence of 57 known phage sequences
(Additional file 5) using GeneFinder and their associ-
ation with SF isolates examined using a Fisher’s Exact
test with Bonferonni’s correction If reads from an isolate
mapped to a prophage reference sequence produced
95% overall nucleotide identity over the complete length
of the phage, the phage was considered to be present in
the isolate.
Additional files
Additional file 1: Table of overrepresentation analysis of SF and iGAS.
(DOC 49 kb)
Additional file 2: Figure of emm gene type reference laboratory
referrals from patients with SF fever from 2004–2014. emm gene type
reference laboratory referrals from patients with SF fever from 2004–2014.
Note this dataset is based on referred isolates only and is therefore
biased: RVPBRU collate SF isolates routinely if part of localised cluster
investigation and numbers of referred isolates for SF isolates are low
(95% CI not included). (DOC 212 kb)
Additional file 3: Table of isolate numbers per region. (DOC 44 kb)
Additional file 4: Table of known virulence factors and antibiotic
resistance determinants examined in genomes. (DOC 35 kb)
Additional file 5: Table of 57 documented phage examined in
genomes. (DOC 34 kb)
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